CONTRAVISORY INVESTMENT MANAGEMENT, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 162 filers reported holding HAEMONETICS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$292,479
+6.4%
3,265
+1.1%
0.08%
+13.7%
Q2 2023$274,832
+2.9%
3,2280.0%0.07%
-2.7%
Q1 2023$267,117
+4092.7%
3,228
+3885.2%
0.08%
+3650.0%
Q4 2022$6,371
+6.2%
810.0%0.00%0.0%
Q3 2022$6,000
+20.0%
810.0%0.00%0.0%
Q2 2022$5,000
-97.2%
81
-98.5%
0.00%
-95.2%
Q3 2015$178,000
-21.6%
5,5000.0%0.04%
-14.3%
Q2 2015$227,000
-8.1%
5,5000.0%0.05%
-2.0%
Q1 2015$247,0005,5000.05%
Other shareholders
HAEMONETICS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders